source stringlengths 2 222 | date stringlengths 19 19 | url stringlengths 22 853 ⌀ | text stringlengths 0 10k ⌀ | title stringlengths 0 701 | context_id stringlengths 1 9 | document_id stringclasses 2
values | document_type stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Seeking Alpha | 2022-03-15 10:18:00 | https://seekingalpha.com/article/4495431-amerisourcebergen-supplying-the-growing-pharmaceutical-demand | Even after its outperformance, the stock has 30%-plus upside and could be worth at least $182/share today. | AmerisourceBergen: Supplying The Growing Pharmaceutical Demand | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Reuters | 2022-03-14 09:54:00 | https://www.reuters.com/business/healthcare-pharmaceuticals/us-should-review-drugmakers-opioid-settlement-tax-breaks-house-panel-2022-03-14/ | The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. House Oversight and Reform Committee said in a statement on Monday. | U.S. should review drugmakers' opioid settlement tax breaks - House panel | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-03-09 14:18:09 | https://www.zacks.com/stock/news/1879811/amerisourcebergen-abc-is-an-incredible-growth-stock-3-reasons-why | AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials. | AmerisourceBergen (ABC) is an Incredible Growth Stock: 3 Reasons Why | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Forbes | 2022-03-09 09:24:16 | https://www.forbes.com/sites/greatspeculations/2022/03/09/amerisourcebergen-supplying-the-growing-pharmaceutical-demand/ | This company is well-positioned to benefit from several trends that will drive long-term growth of pharmaceutical sales. | AmerisourceBergen: Supplying The Growing Pharmaceutical Demand | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-03-07 12:00:16 | https://www.zacks.com/stock/news/1878520/amerisourcebergen-abc-hits-52-week-high-what-s-aiding-it | Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business. | AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-03-07 09:00:19 | https://www.zacks.com/stock/news/1878245/5-dividend-growth-stocks-for-safe-and-consistent-income | J.B. Hunt (JBHT), Archer-Daniels (ADM), NVIDIA (NVDA), Tractor Supply (TSCO) and AmerisourceBergen (ABC) could be compelling picks for investors seeking safe and consistent income. | 5 Dividend Growth Stocks for Safe and Consistent Income | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-03-04 13:03:53 | https://www.zacks.com/stock/news/1877735/amerisourcebergen-abc-up-5-5-since-last-earnings-report-can-it-continue | AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? | AmerisourceBergen (ABC) Up 5.5% Since Last Earnings Report: Can It Continue? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-03-03 08:27:06 | https://www.zacks.com/stock/news/1876587/here-s-why-you-should-invest-in-amerisourcebergen-abc-stock | AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. | Here's Why You Should Invest in AmerisourceBergen (ABC) Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-28 10:45:11 | https://www.zacks.com/stock/news/1874459/is-amerisourcebergen-abc-outperforming-other-medical-stocks-this-year | Here is how AmerisourceBergen (ABC) and Celularity, Inc. (CELU) have performed compared to their sector so far this year. | Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-02-19 02:36:06 | https://seekingalpha.com/article/4488539-amerisourcebergen-another-all-time-high | 100% technical buy signal. | AmerisourceBergen - Another All Time High | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-17 13:05:09 | https://www.zacks.com/stock/news/1869271/amerisourcebergen-abc-is-a-great-momentum-stock-should-you-buy | Does AmerisourceBergen (ABC) have what it takes to be a top stock pick for momentum investors? Let's find out. | AmerisourceBergen (ABC) is a Great Momentum Stock: Should You Buy? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-14 13:56:04 | https://www.zacks.com/stock/news/1867312/3-reasons-growth-investors-will-love-amerisourcebergen-abc | AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials. | 3 Reasons Growth Investors Will Love AmerisourceBergen (ABC) | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-11 13:05:09 | https://www.zacks.com/stock/news/1866569/amerisourcebergen-abc-upgraded-to-buy-here-s-why | AmerisourceBergen (ABC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). | AmerisourceBergen (ABC) Upgraded to Buy: Here's Why | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-07 15:24:05 | https://www.zacks.com/commentary/1863638/the-stock-picking-puzzle-putting-the-pieces-together | The Stock-Picking Puzzle: Putting The Pieces Together | The Stock-Picking Puzzle: Putting The Pieces Together | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-02-03 00:20:33 | https://seekingalpha.com/article/4483775-amerisourcebergen-q1-2022-earnings-wealth-compounder | AmerisourceBergen has a durable business model and is seeing revenue and margin growth. It has a strong track record of shareholder returns, and has tailwinds in COVID treatments and vaccines. | AmerisourceBergen: A Steady Wealth Compounder You'll Want To Own | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-02-02 12:32:05 | https://seekingalpha.com/article/4483612-amerisourcebergens-abc-ceo-steve-collis-on-q1-2022-results-earnings-call-transcript | AmerisourceBergen's (ABC) CEO Steve Collis on Q1 2022 Results - Earnings Call Transcript | AmerisourceBergen's (ABC) CEO Steve Collis on Q1 2022 Results - Earnings Call Transcript | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-02 10:46:21 | https://www.zacks.com/stock/news/1861239/amerisourcebergen-abc-q1-earnings-lag-estimates-revenues-beat | AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth. | AmerisourceBergen (ABC) Q1 Earnings Lag Estimates, Revenues Beat | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2022-02-02 09:28:29 | https://www.benzinga.com/news/earnings/22/02/25364120/amerisourcebergen-q1-earnings-beats-by-a-whisker | AmerisourceBergen Corp's ABC Q1 FY22 adjusted EPS reached $2.58, up 18.3% Y/Y, marginally beating the consensus of $2.57. Thousands of new traders are learning the ins and outs on how to find profitable trades every day with Benzinga Trading School. | AmerisourceBergen Q1 Earnings Beats By A Whisker | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-02-02 09:15:12 | https://www.zacks.com/stock/news/1861140/amerisourcebergen-abc-misses-q1-earnings-estimates | AmerisourceBergen (ABC) delivered earnings and revenue surprises of -0.39% and 0.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? | AmerisourceBergen (ABC) Misses Q1 Earnings Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2022-02-02 06:44:51 | https://www.marketwatch.com/story/amerisourcebergen-matches-consensus-for-profit-and-revenue-raises-full-year-guidance-2022-02-02 | AmerisourceBergen Corp. ABC, +1.07% matched consensus estimates for profit and revenue for its fiscal first quarter on Wednesday, and raised its full-year guidance. The Conshocken, Pa. | AmerisourceBergen matches consensus for profit and revenue, raises full-year guidance | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-01-27 12:19:14 | https://www.zacks.com/stock/news/1858324/amerisourcebergen-abc-to-post-q1-earnings-what-s-in-store | AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment. | AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-01-26 16:09:51 | https://www.zacks.com/stock/news/1857694/amerisourcebergen-abc-reports-next-week-wall-street-expects-earnings-growth | AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | AmerisourceBergen (ABC) Reports Next Week: Wall Street Expects Earnings Growth | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-01-24 11:35:17 | https://www.zacks.com/stock/news/1856160/amerisourcebergen-abc-is-a-top-ranked-momentum-stock-should-you-buy | Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. | AmerisourceBergen (ABC) is a Top-Ranked Momentum Stock: Should You Buy? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-01-11 10:45:18 | https://www.zacks.com/stock/news/1850220/here-s-why-you-should-retain-amerisourcebergen-abc-stock | AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment. However, stiff competition is a woe. | Here's Why You Should Retain AmerisourceBergen (ABC) Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2022-01-04 16:15:00 | https://www.businesswire.com/news/home/20220104005911/en/AmerisourceBergen-Announces-Date-and-Time-for-First-Quarter-Fiscal-2022-Earnings-Release/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2022 on Wednesday, February 2, 2022 prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the re... | AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-12-27 12:59:06 | https://www.zacks.com/stock/news/1843900/amerisourcebergen-abc-hits-52-week-high-what-s-aiding-it | Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business. | AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-12-25 09:00:00 | https://seekingalpha.com/article/4476581-options-income-series-earn-high-income-safely-consistently-december-2021 | We explain why selling the cash-covered puts and covered calls is a safer choice and earns a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable. | Options Income Series: Earn High Income Safely And Consistently - December 2021 | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-12-16 18:23:02 | https://www.zacks.com/stock/news/1840338/has-amerisourcebergen-abc-outpaced-other-medical-stocks-this-year | Here is how AmerisourceBergen (ABC) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year. | Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-12-16 10:45:16 | https://www.zacks.com/stock/news/1840136/has-amerisourcebergen-abc-outpaced-other-medical-stocks-this-year | Here is how AmerisourceBergen (ABC) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year. | Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-12-08 08:19:02 | https://www.zacks.com/stock/news/1836676/here-s-why-you-should-invest-in-amerisourcebergen-abc-stock | AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment. | Here's Why You Should Invest in AmerisourceBergen (ABC) Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-11-15 14:30:03 | https://www.benzinga.com/government/21/11/24101830/mckesson-cardinal-health-amerisourcebergen-face-95b-opioid-trial-in-washington-reuters | A Washington state trial against McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) for the U.S. opioid epidemic is slated to kick off today, Reuters reported. Washington Attorney General Bob Ferguson declined to join a $26 billion nationwide settlement and has acc... | McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-11-11 16:49:36 | https://seekingalpha.com/article/4468628-dividend-increases-october-30-november-5-2021 | In this article series, we provide a weekly summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases. | Dividend Increases: October 30-November 5, 2021 | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-11-08 10:45:33 | https://www.zacks.com/stock/news/1825011/amerisourcebergen-abc-soars-to-52-week-high-time-to-cash-out | AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. | AmerisourceBergen (ABC) Soars to 52-Week High, Time to Cash Out? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-11-05 21:40:08 | https://seekingalpha.com/article/4466267-3-reasons-amerisourcebergen-stock-earnings-swan-worth-buying-today-dividend | 3 Reasons AmerisourceBergen Is A SWAN Worth Buying Today | 3 Reasons AmerisourceBergen Is A SWAN Worth Buying Today | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-11-04 11:59:06 | https://seekingalpha.com/article/4465439-amerisourcebergen-corporation-abc-ceo-steve-collis-on-q4-fiscal-2021-results-earnings-call | AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 Fiscal 2021 Results - Earnings Call Transcript | AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q4 Fiscal 2021 Results - Earnings Call Transcript | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-11-04 09:11:22 | https://www.zacks.com/stock/news/1823347/amerisourcebergen-abc-q4-earnings-and-revenues-surpass-estimates | AmerisourceBergen (ABC) delivered earnings and revenue surprises of 1.27% and 3.92%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? | AmerisourceBergen (ABC) Q4 Earnings and Revenues Surpass Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2021-10-21 06:45:00 | https://www.fool.com/investing/2021/10/21/3-stocks-to-buy-as-the-economy-recovers/ | These companies have been delivering strong results, and investors should expect that to continue next year. | 3 Stocks to Buy as the Economy Recovers | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-10-13 11:30:30 | https://www.zacks.com/stock/news/1810028/here-s-why-amerisourcebergen-abc-is-a-strong-value-stock | Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. | Here's Why AmerisourceBergen (ABC) is a Strong Value Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-10-06 10:30:36 | https://www.zacks.com/stock/news/1806052/here-s-why-you-should-invest-in-amerisourcebergen-abc-stock | AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment. | Here's Why You Should Invest in AmerisourceBergen (ABC) Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-09-28 14:58:52 | https://www.benzinga.com/government/21/09/23140209/drug-distributors-ink-first-opioid-settlement-with-cherokee-nation | Cardinal Health Inc (NYSE: CAH), McKesson Corporation (NYSE: MCK), and AmerisourceBergen Corp (NYSE: ABC), accused of U.S. addiction crisis, have struck a settlement with a tribal government, Reuters reports. As part of the deal with Cherokee Nation's territory in Oklahoma, the three companies will pay $75 million over... | Drug Distributors Ink First Opioid Settlement With Cherokee Nation | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-09-28 10:59:00 | https://www.businesswire.com/news/home/20210928005857/en/AmerisourceBergen-Unveils-New-Global-Headquarters-in-Conshohocken-PA-Announces-Great-Place-to-Work%C2%AE-Recognition/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Today, AmerisourceBergen (AB), a global healthcare company, hosted a ribbon cutting ceremony to commemorate the opening of its new global headquarters in Conshohocken, Pa. The 429,000 sq. ft. facility designed by Gensler includes tech-enabled conference and business centers, a fitnes... | AmerisourceBergen Unveils New Global Headquarters in Conshohocken, PA & Announces Great Place to Work® Recognition | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-09-15 19:07:46 | https://seekingalpha.com/article/4455454-3-stock-ideas-for-an-expensive-market | With most stock indices near all-time highs and lofty valuations on most mega-cap stocks, it can be difficult to find good long-term values right now in the overall stock market. At the individual stock level, however, there are a few solid values even within the components of the S&P 500 index that aren't cyclical in ... | 3 Stock Ideas For An Expensive Market | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-09-07 12:31:13 | https://www.zacks.com/stock/news/1792837/here-s-why-you-should-retain-amerisourcebergen-abc-stock-now | AmerisourceBergen (ABC) continues to gain traction from the robust pharmaceutical segment. | Here's Why You Should Retain AmerisourceBergen (ABC) Stock Now | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-09-04 18:08:00 | https://www.businesswire.com/news/home/20210904005012/en/Distributors-Announce-Proposed-Opioid-Settlement-Will-Proceed-to-Next-Phase/ | CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that, under the previously announced proposed settlement agreement and process designed to resolve the opioid claims of state and local governmental enti... | Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-09-03 13:00:11 | https://www.zacks.com/stock/news/1791207/why-is-amerisourcebergen-abc-up-2-5-since-last-earnings-report | AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? | Why Is AmerisourceBergen (ABC) Up 2.5% Since Last Earnings Report? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-09-02 16:15:00 | https://www.businesswire.com/news/home/20210902005641/en/AmerisourceBergen-to-Participate-in-Upcoming-Investor-Conferences/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Morgan Stanley 19th Annual Global Healthcare Conference, to be held on September 9-10 & September 13-15, 2021; and Baird 2021 Global Healthcare... | AmerisourceBergen to Participate in Upcoming Investor Conferences | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-08-04 20:49:51 | https://seekingalpha.com/article/4445103-amerisourcebergen-stock-boring-but-beautiful-buy-for-your-rich-retirement | AmerisourceBergen: Boring But Beautiful Buy For Your Rich Retirement | AmerisourceBergen: Boring But Beautiful Buy For Your Rich Retirement | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-08-04 10:12:48 | https://www.benzinga.com/news/earnings/21/08/22320428/amerisourcebergen-stock-gains-as-q3-earnings-tops-wall-street-estimates-raises-fy21-eps-guidance | AmerisourceBergen Corporation's (NYSE: ABC) Q3 for fiscal 2021 reports an adjusted EPS of $2.16, topping the analyst consensus estimate of $2.03. Revenue of $53.4 billion increased 17.7% Y/Y, beating the analyst consensus estimate of $52.05 billion. | AmerisourceBergen Stock Gains As Q3 Earnings Tops Wall Street Estimates; Raises FY21 EPS Guidance | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-08-04 09:10:16 | https://www.zacks.com/stock/news/1774012/amerisourcebergen-abc-beats-q3-earnings-and-revenue-estimates | AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.46% and 3.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock? | AmerisourceBergen (ABC) Beats Q3 Earnings and Revenue Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-08-04 06:30:00 | https://www.businesswire.com/news/home/20210804005182/en/AmerisourceBergen-Reports-Fiscal-2021-Third-Quarter-Results/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent year-over-year to $53.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (E... | AmerisourceBergen Reports Fiscal 2021 Third Quarter Results | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-26 13:50:19 | https://www.zacks.com/stock/news/1767731/will-amerisourcebergen-abc-beat-estimates-again-in-its-next-earnings-report | AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Will AmerisourceBergen (ABC) Beat Estimates Again in Its Next Earnings Report? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-22 10:42:29 | https://www.zacks.com/stock/news/1765876/us-states-get-26b-settlement-deal-in-opioid-abuse-litigation | Attorney generals of several states reach settlement deal with J&J (JNJ) and three drug distributors - MCK, CAH and ABC - related to thousands of opioid abuse litigations. Non-participating states may join the deal soon. | US States Get $26B Settlement Deal in Opioid Abuse Litigation | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo Finance | 2021-07-21 19:57:44 | https://www.youtube.com/watch?v=JeAOSHzakKA | Chris Meekins, Healthcare Policy Research Analyst at Raymond James, joins Yahoo Finance's Kristin Myers and Alexis Christoforous to discuss healthcare talks in Washington this week and the latest news on the opioid lawsuits. | States announce $26 billion settlement to resolve opioid lawsuits: RPT | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2021-07-21 16:47:49 | https://investorplace.com/2021/07/what-did-the-stock-market-do-today-3-big-stories-to-catch-up-on-10/ | What did the stock market do today? It began to address the opioid crisis, it tuned in on Bitcoin and it saw a devastating Olympics loss. | What Did the Stock Market Do Today? 3 Big Stories to Catch Up On. | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-07-21 14:15:00 | https://www.businesswire.com/news/home/20210721005837/en/Distributors-Announce-Proposed-Opioid-Settlement-Agreement/ | CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a subst... | Distributors Announce Proposed Opioid Settlement Agreement | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-21 07:01:03 | https://www.zacks.com/stock/news/1764761/amerisourcebergen-abc-soars-3-5-is-further-upside-left-in-the-stock | AmerisourceBergen (ABC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road. | AmerisourceBergen (ABC) Soars 3.5%: Is Further Upside Left in the Stock? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Reuters | 2021-07-20 10:56:00 | https://www.reuters.com/business/healthcare-pharmaceuticals/drug-distributors-pay-up-11-bln-settle-new-york-opioid-case-2021-07-20/ | NEW YORK, July 20 (Reuters) - The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic, the state's attorney general said on Tuesday. | Drug distributors settle New York opioid claims for up to $1.18 bln | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2021-07-20 09:46:54 | https://www.marketwatch.com/story/mckesson-cardinal-health-amerisourcebergen-stocks-surge-after-11-billion-opioid-settlement-with-ny-ag-2021-07-20 | Shares of McKesson Corp. , Cardinal Health Inc. and AmerisourceBergen Corp. all surged more than 4% in morning trading Tuesday, after the New York Attorney General Letitia James announced a $1.1 billion settlement agreement with the drug distributors to combat the opioid epidemic. James said the agreement resolves clai... | McKesson, Cardinal Health, AmerisourceBergen stocks surge after $1.1 billion opioid settlement with NY AG | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-16 10:09:33 | https://www.zacks.com/stock/news/1762717/medtech-thrives-on-healthcare-it-in-2021-4-stocks-to-focus-on | Health IT stocks like HealthEquity (HQY), Veeva Systems (VEEV), Tabula Rasa (TRHC) and Allscripts (MDRX) are expected to continue their run over the next few months. | MedTech Thrives on Healthcare IT in 2021: 4 Stocks to Focus on | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-08 10:32:08 | https://www.zacks.com/stock/news/1759170/why-you-shouldnt-bet-against-amerisourcebergen-abc-stock | AmerisourceBergen (ABC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. | Why You Shouldn't Bet Against AmerisourceBergen (ABC) Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-07-08 09:01:20 | https://www.zacks.com/stock/news/1759015/heres-why-you-should-retain-amerisourcebergen-abc-now | AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment. | Here's Why You Should Retain AmerisourceBergen (ABC) Now | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-06-24 16:15:00 | https://www.businesswire.com/news/home/20210624005980/en/AmerisourceBergen-Announces-Date-and-Time-for-Third-Quarter-Fiscal-2021-Earnings-Release/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2021 on Wednesday, August 4, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the res... | AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-06-21 10:32:41 | https://www.zacks.com/stock/news/1742311/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick | Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. | Are You a Value Investor? This 1 Stock Could Be the Perfect Pick | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-06-11 10:58:46 | https://seekingalpha.com/article/4434321-investing-opportunities-animal-companionship-industry-growing-at-6-percent-annually | The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across developed markets. | Overview Of Opportunities In Animal Companionship: A $200B Industry Growing At 6.1% Annually | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-06-09 10:31:24 | https://www.zacks.com/stock/news/1680255/heres-why-you-should-retain-amerisourcebergen-abc-now | AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment. | Here's Why You Should Retain AmerisourceBergen (ABC) Now | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-06-04 16:15:00 | https://www.businesswire.com/news/home/20210604005581/en/AmerisourceBergen-to-Participate-in-Upcoming-Investor-Conferences/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate virtually in the following upcoming investor conferences: Goldman Sachs 42nd Annual Global Healthcare Conference, to be held on June 8-11, 2021; and Baird Healthcare ESG Symposium, to be held on June 1... | AmerisourceBergen to Participate in Upcoming Investor Conferences | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Forbes | 2021-06-02 09:20:49 | https://www.forbes.com/sites/brucejapsen/2021/06/02/walgreens-completes-65b-sale-of--european-distribution-business-to-amerisourcebergen/ | The large drug wholesaler AmerisourceBergen completed its acquisition of the majority of Walgreens Boots Alliance's “Alliance Healthcare” wholesale distribution business for $6.5 billion. | Walgreens Completes $6.5B Sale Of European Distribution Business To AmerisourceBergen | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Insider | 2021-05-26 12:52:40 | https://www.businessinsider.com/pharmacy-stocks-amazon-physical-pharmacy-drug-stores-cvs-walgreens-riteaid-2021-5 | Shares of drug retailers including Walgreens Boots Alliance and CVS dropped on Wednesday, as Amazon was reported to be looking at options to set up physical pharmacy locations in the US. Talks at Amazon about setting up standalone pharmacies are mostly exploratory and there are no firm plans to open physical location... | Pharmacy stocks tumble on report Amazon is weighing a push into physical pharmacies (AMZN, CVS, RAD, WAG, CAH, MCK, ABC) | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-05-22 07:30:00 | https://seekingalpha.com/article/4430512-amerisourcebergen-a-minus-rated-healthcare-blue-chip-with-17-years-of-dividend-growth | ABC benefits from a very strong balance sheet. ABC has durable competitive advantages. | AmerisourceBergen: A-Rated Healthcare Blue Chip With 17 Years Of Dividend Growth | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2021-05-05 14:12:20 | https://www.benzinga.com/news/earnings/21/05/20967343/amerisourcebergen-stock-dives-after-q2-earnings-fall-short-of-expectations | AmerisourceBergen Corporation (NYSE: ABC) shares dropped after the company's Q2 for fiscal 2021 failed to meet the consensus estimates. It reported an adjusted EPS of $2.53 topped the analyst consensus estimate of $2.48. | AmerisourceBergen Stock Dives After Q2 Earnings Fall Short Of Expectations | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-05-05 09:24:37 | https://www.zacks.com/stock/news/1504268/amerisourcebergen-abc-q2-earnings-beat-revenues-miss | AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth. | AmerisourceBergen (ABC) Q2 Earnings Beat, Revenues Miss | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-05-05 08:39:11 | https://www.zacks.com/stock/news/1503799/amerisourcebergen-abc-q2-earnings-top-estimates | AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.80% and -1.58%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock? | AmerisourceBergen (ABC) Q2 Earnings Top Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2021-05-05 06:42:12 | https://www.marketwatch.com/story/amerisourcebergen-stock-falls-after-profit-beats-forecasts-but-revenue-was-a-bit-light-2021-05-05 | Shares of AmerisourceBergen Corp. fell 0.7% in premarket trading Wednesday, after the pharmaceuticals and health care products company reported a first-quarter profit that beat expectations but revenue that came up a bit light. Net income fell to $435.3 million, or $2.10 a share, from $960.3 million, or $4.64 a share, ... | AmerisourceBergen stock falls after profit beats forecasts but revenue was a bit light | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-05-05 06:30:00 | https://www.businesswire.com/news/home/20210505005225/en/AmerisourceBergen-Reports-Fiscal-2021-Second-Quarter-Results/ | CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent year-over-year to $49.2 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (... | AmerisourceBergen Reports Fiscal 2021 Second Quarter Results | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-05-04 09:47:50 | https://www.zacks.com/stock/news/1498446/why-amerisourcebergen-abc-might-surprise-this-earnings-season | AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. | Why AmerisourceBergen (ABC) Might Surprise This Earnings Season | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-04-30 11:16:11 | https://www.zacks.com/stock/news/1479229/amerisourcebergen-abc-to-post-q2-earnings-whats-in-store | AmerisourceBergen's (ABC) fiscal second-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units. | AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-04-21 09:46:27 | https://www.zacks.com/stock/news/1430583/heres-why-you-should-retain-amerisourcebergen-abc-stock | AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches. | Here's Why You Should Retain AmerisourceBergen (ABC) Stock | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-04-08 12:52:17 | https://www.zacks.com/stock/news/1365235/all-you-need-to-know-about-amerisourcebergen-abc-rating-upgrade-to-buy | AmerisourceBergen (ABC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. | All You Need to Know About AmerisourceBergen (ABC) Rating Upgrade to Buy | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-04-01 16:15:00 | https://www.businesswire.com/news/home/20210401005885/en/AmerisourceBergen-Announces-Date-and-Time-for-Second-Quarter-Fiscal-2021-Earnings-Release/ | VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2021 on Wednesday, May 5, 2021, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the resul... | AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-03-30 17:35:00 | https://www.businesswire.com/news/home/20210330006090/en/AmerisourceBergen-Closes-1525000000-0.737-Senior-Notes-Due-2023-and-1000000000-2.700-Senior-Notes-Due-2031/ | VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $1,525,000,000 aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1,000,000,000 aggregate principal amount of its 2.700% Senior Notes due Marc... | AmerisourceBergen Closes $1,525,000,000 0.737% Senior Notes Due 2023 and $1,000,000,000 2.700% Senior Notes Due 2031 | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-03-26 11:22:04 | https://www.zacks.com/stock/news/1299360/amerisourcebergen-abc-hits-new-52-week-high-whats-driving-it | AmerisourceBergen (ABC) is optimistic about maintaining a robust segmental performance amid the pandemic-led business disruptions. | AmerisourceBergen (ABC) Hits New 52-Week High: What's Driving It? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-03-25 18:41:00 | https://www.businesswire.com/news/home/20210325005972/en/AmerisourceBergen-Prices-1.525-Billion-0.737-Senior-Notes-Due-2023-and-1.0-Billion-2.700-Senior-Notes-Due-2031/ | VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $1.525 billion aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the “2023 Notes”) and $1.0 billion aggregate principal amount of its 2.700% Senior Notes due March 15, 2031 (the “2031 Not... | AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031 | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-03-24 06:28:06 | https://seekingalpha.com/article/4415762-amerisourcebergen-this-swan-is-still-on-sale-why | AmerisourceBergen has underperformed the market, despite strong and steady performance. | AmerisourceBergen: This SWAN Is Still On Sale, Here's Why | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-03-18 05:00:40 | https://seekingalpha.com/article/4414701-building-dividend-growth-portfolio-from-scratch-in-today-s-expensive-market | The current valuation suggests that investors purchasing the index today could suffer through negative returns for the next 2 to 3 years or longer. Low interest rates have generated strong demand for dividend growth stocks. | Building A Dividend Growth Portfolio From Scratch In Today's Expensive Market | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-03-10 12:08:31 | https://www.zacks.com/commentary/1276557/3-stocks-to-capitalize-on-promising-dental-supplies-industry | 3 Stocks to Capitalize on Promising Dental Supplies Industry | 3 Stocks to Capitalize on Promising Dental Supplies Industry | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-03-06 12:08:20 | https://www.zacks.com/stock/news/1274635/why-is-amerisourcebergen-abc-down-63-since-last-earnings-report | AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? | Why Is AmerisourceBergen (ABC) Down 6.3% Since Last Earnings Report? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2021-03-02 11:33:44 | https://www.youtube.com/watch?v=QEoCoL6zh0A | Steve Collis, AmerisourceBergen CEO, joins 'Squawk on the Street' to discuss the role his company has played in the federal retail pharmacy program and his thoughts on the vaccine distribution. | AmerisourceBergen CEO on how U.S. vaccine distribution is going | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-02-04 14:53:06 | https://seekingalpha.com/article/4403508-amerisourcebergen-corporation-abc-ceo-steve-collis-on-q1-2021-results-earnings-call | AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q1 2021 Results - Earnings Call Transcript | AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q1 2021 Results - Earnings Call Transcript | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-02-04 10:35:29 | https://www.zacks.com/stock/news/1257484/amerisourcebergen-abc-q1-earnings-revenues-beat-estimates | AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth. | AmerisourceBergen (ABC) Q1 Earnings & Revenues Beat Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-02-04 08:19:31 | https://www.zacks.com/stock/news/1257342/amerisourcebergen-abc-q1-earnings-and-revenues-top-estimates | AmerisourceBergen (ABC) delivered earnings and revenue surprises of 12.37% and 3.84%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock? | AmerisourceBergen (ABC) Q1 Earnings and Revenues Top Estimates | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2021-02-04 06:43:40 | https://www.marketwatch.com/story/amerisourcebergens-stock-surges-after-profit-and-revenue-beats-raised-outlook-2021-02-04 | Shares of AmerisourceBergen Corp. rallied 2.9% in premarket trading Thursday, after the pharmaceuticals and health care products development and delivery company reported fiscal first-quarter profit and revenue that beat expectations and raised its full-year outlook. Net income for the quarter to Dec. 31 rose to $374.8... | AmerisourceBergen's stock surges after profit and revenue beats, raised outlook | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-02-04 06:30:00 | https://www.businesswire.com/news/home/20210204005165/en/AmerisourceBergen-Reports-Fiscal-2021-First-Quarter-Results/ | VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent year-over-year to $52.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share... | AmerisourceBergen Reports Fiscal 2021 First Quarter Results | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-02-03 09:06:08 | https://www.zacks.com/stock/news/1256615/why-amerisourcebergen-abc-might-surprise-this-earnings-season | AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. | Why AmerisourceBergen (ABC) Might Surprise This Earnings Season | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-02-01 10:37:09 | https://www.zacks.com/stock/news/1255178/amerisourcebergen-abc-to-post-q1-earnings-whats-in-store | AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units. | AmerisourceBergen (ABC) to Post Q1 Earnings: What's in Store? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2021-01-27 11:22:20 | https://www.gurufocus.com/news/1342030/a-trio-of-low-pricetofreecashflow-ratio-stocks-to-consider | When looking for value opportunities, one method is to choose stocks whose trailing 12-month price-to-free-cash-flow ratios are low compared to that of the S&P 500 index, which stands at 15.28 as of the writing of this article. In my view, these equities are more likely to be selling at a compelling price. | A Trio of Low Price-to-Free-Cash-Flow Ratio Stocks to Consider | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-01-25 09:47:15 | https://www.zacks.com/stock/news/1251257/heres-why-you-should-retain-amerisourcebergen-abc-now | AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches. | Here's Why You Should Retain AmerisourceBergen (ABC) Now | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-01-20 12:48:28 | https://www.zacks.com/stock/news/1249286/is-amerisourcebergen-abc-stock-undervalued-right-now | Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | Is AmerisourceBergen (ABC) Stock Undervalued Right Now? | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-01-14 16:30:00 | https://www.businesswire.com/news/home/20210114005937/en/AmerisourceBergen-Announces-Quarterly-Dividend/ | VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors declared a quarterly dividend of $0.44 per common share, payable March 1, 2021, to stockholders of record at the close of business on February 12, 2021. About AmerisourceBergen AmerisourceBergen pro... | AmerisourceBergen Announces Quarterly Dividend | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2021-01-07 12:02:19 | https://www.zacks.com/stock/news/1242601/amerisourcebergen-abc-wba-ink-deal-to-focus-on-core-arms | AmerisourceBergen (ABC) and Walgreens (WBA) enter into a key strategic deal to boost focus on core businesses, while extending their partnership. | AmerisourceBergen (ABC), WBA Ink Deal to Focus on Core Arms | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Invezz | 2021-01-06 15:34:25 | https://invezz.com/news/2021/01/06/walgreens-to-sell-its-distribution-unit-to-amerisourcebergen-for-4-78-billion/ | In an announcement on Wednesday, Walgreens Boots Alliance Inc (NASDAQ: WBA) said it will sell its distribution business to AmerisourceBergen Corp (NYSE: ABC) for £4.78 billion. Walgreens shares were seen more than 2% up in premarket trading on Wednesday and jumped another 2.5% in the next few hours. | Walgreens to sell its distribution unit to AmerisourceBergen for £4.78 billion | ABC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.